Skip to main content
. 2021 Jan 5;34(2):654–666. doi: 10.1007/s13577-020-00473-0

Fig. 2.

Fig. 2

miR-675-3p may represent a prognostic biomarker in melanoma. a Kaplan–Meier analyses in which melanoma patients were separated based upon median miR-675-3p expression levels revealed that high miR-675-3p expression was associated with poorer OS. b X-tile was used to calculate an optimal miR-675-3p expression cut-off value, which revealed that elevated expression of this miRNA was associated with poorer melanoma patient OS